Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: 4 HF therapies to keep an eye on | STROKE AF data | Mavacamten approved for obstructive HCM
Saturday, May 7, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

4 promising heart failure therapies interventional cardiologists should keep an eye on

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead. 

READ MORE >
Illustration showing four innovative heart failure technologies: The V-Wave interaterial shunt to relieve pressures between the left and right sides of the heart; the Carillon Transcatheter mitral valve annuloplasty system; the Revivent TC system and the AccuCinch device. Interventional cardiology heart failure cleveland clinic
Share on Twitter Share on Facebook Share on Linkedin

4 promising heart failure therapies interventional cardiologists should keep an eye on

Share on Twitter Share on Facebook Share on Linkedin
Illustration showing four innovative heart failure technologies: The V-Wave interaterial shunt to relieve pressures between the left and right sides of the heart; the Carillon Transcatheter mitral valve annuloplasty system; the Revivent TC system and the AccuCinch device. Interventional cardiology heart failure cleveland clinic
The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead. 
READ MORE >

STROKE AF study shows insertable cardiac monitors detect 4 times more AFib than Holter monitoring

New data from the STROKE AF clinical trial shows large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring with Holter and 30-day external monitors had fewer AFib episodes detected that continuous implantable cardiac monitors.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

STROKE AF study shows insertable cardiac monitors detect 4 times more AFib than Holter monitoring

Share on Twitter Share on Facebook Share on Linkedin
New data from the STROKE AF clinical trial shows large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring with Holter and 30-day external monitors had fewer AFib episodes detected that continuous implantable cardiac monitors.
READ MORE >

FDA approves mavacamten for obstructive hypertrophic cardiomyopathy

The FDA’s approval was based on data from the EXPLORER-HCM trial, which showed that mavacamten was superior to a placebo for treating obstructive HCM and associated with no significant long-term, treatment-related adverse events.

READ MORE >
mavacamten
Share on Twitter Share on Facebook Share on Linkedin

FDA approves mavacamten for obstructive hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
mavacamten
The FDA’s approval was based on data from the EXPLORER-HCM trial, which showed that mavacamten was superior to a placebo for treating obstructive HCM and associated with no significant long-term, treatment-related adverse events.
READ MORE >

Links to the late-breaking studies at Heart Rhythm 2022

Heart Rhythm 2022, held from April 28 to May 1 in San Francisco, included a wide range of studies presented by some of the industry's leading specialists. 

READ MORE >
A late-breakling study session at the 2022 Heart Rhythm DSociety (HRS) conference. Here is a list of all the late breaking studies at #HeartRhythm22
Share on Twitter Share on Facebook Share on Linkedin

Links to the late-breaking studies at Heart Rhythm 2022

Share on Twitter Share on Facebook Share on Linkedin
A late-breakling study session at the 2022 Heart Rhythm DSociety (HRS) conference. Here is a list of all the late breaking studies at #HeartRhythm22
Heart Rhythm 2022, held from April 28 to May 1 in San Francisco, included a wide range of studies presented by some of the industry's leading specialists. 
READ MORE >

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance. 

READ MORE >
Boston Scientific’s EMBOLD Fibered Detachable Coil.
Share on Twitter Share on Facebook Share on Linkedin

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific’s EMBOLD Fibered Detachable Coil.
It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance. 
READ MORE >

Statin reduces risk for non-obstructive CAD patients but no significant risk reduction for aspirin

The results of a study published in Radiology: Cardiothoracic Imaging call into question the value of initiating aspirin therapy in certain instances.

READ MORE >
Pills
Share on Twitter Share on Facebook Share on Linkedin

Statin reduces risk for non-obstructive CAD patients but no significant risk reduction for aspirin

Share on Twitter Share on Facebook Share on Linkedin
Pills
The results of a study published in Radiology: Cardiothoracic Imaging call into question the value of initiating aspirin therapy in certain instances.
READ MORE >

New-look protocol boosts outcomes among AFib patients in the ER

A large proportion of patients with atrial fibrillation (AFib) end up in emergency rooms (ERs), but there are inherent issues with most hospital ERs handing off these patients to electrophysiologists for follow-up care.

READ MORE >
A large proportion of patients with atrial fibrillation (AF) end up in emergency rooms (ERs), but there are inherent issues with most hospital ERs handing off these patients to electrophysiologists for followup care. The ER2EP Study presented at the 2022 HRS meeting found better results of there is an organized pathway for AF patients to follow. #AFib
Share on Twitter Share on Facebook Share on Linkedin

New-look protocol boosts outcomes among AFib patients in the ER

Share on Twitter Share on Facebook Share on Linkedin
A large proportion of patients with atrial fibrillation (AF) end up in emergency rooms (ERs), but there are inherent issues with most hospital ERs handing off these patients to electrophysiologists for followup care. The ER2EP Study presented at the 2022 HRS meeting found better results of there is an organized pathway for AF patients to follow. #AFib
A large proportion of patients with atrial fibrillation (AFib) end up in emergency rooms (ERs), but there are inherent issues with most hospital ERs handing off these patients to electrophysiologists for follow-up care.
READ MORE >

Internal pump malfunction in the Medtronic HVAD found in three patients

The FDA and Medtronic warn some Heartware Ventricular Assist Device (HVAD) systems have a defect that may cause pump thrombosis.

READ MORE >
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that patients who have a Medtronic Heartware Ventricular Assist Device (HVAD) System and present with pump thrombosis may have a welding defect in the internal pump, causing it to malfunction. Medtronic and the FDA issues the notice to providers April 28, 2022.
Share on Twitter Share on Facebook Share on Linkedin

Internal pump malfunction in the Medtronic HVAD found in three patients

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that patients who have a Medtronic Heartware Ventricular Assist Device (HVAD) System and present with pump thrombosis may have a welding defect in the internal pump, causing it to malfunction. Medtronic and the FDA issues the notice to providers April 28, 2022.
The FDA and Medtronic warn some Heartware Ventricular Assist Device (HVAD) systems have a defect that may cause pump thrombosis.
READ MORE >

Combining certain BP medications with NSAIDs linked to kidney damage—acetaminophen seen as a safer option

A team of researchers used computer science and mathematics to study the "triple whammy" of diuretics, RAS inhibitors and NSAIDs.

READ MORE >
Based on this evidence, its is recommended using monotherapy with ticagrelor or prasugrel after one to three months of DAPT after PCI for acute coronary syndrome (ACS), but not using monotherapy of aspirin or clopidogrel unless the patient has a high bleeding risk.
Share on Twitter Share on Facebook Share on Linkedin

Combining certain BP medications with NSAIDs linked to kidney damage—acetaminophen seen as a safer option

Share on Twitter Share on Facebook Share on Linkedin
Based on this evidence, its is recommended using monotherapy with ticagrelor or prasugrel after one to three months of DAPT after PCI for acute coronary syndrome (ACS), but not using monotherapy of aspirin or clopidogrel unless the patient has a high bleeding risk.
A team of researchers used computer science and mathematics to study the "triple whammy" of diuretics, RAS inhibitors and NSAIDs.
READ MORE >

How the science behind COVID-19 vaccines could transform care for heart attack patients

A technique seen in the Pfizer-BioNTech and Moderna COVID-19 vaccines may be able to help heart cells repair themselves, according to new research out of the Netherlands. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

How the science behind COVID-19 vaccines could transform care for heart attack patients

Share on Twitter Share on Facebook Share on Linkedin
A technique seen in the Pfizer-BioNTech and Moderna COVID-19 vaccines may be able to help heart cells repair themselves, according to new research out of the Netherlands. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme